AIZ Assurant, Inc.
Assurant, Inc. provides protection services to connected devices, homes, and automobiles in North America, Latin America, Europe, and the Asia Pacific. It operates through Global Lifestyle and Global Housing segments. The Global Lifestyle segment offers mobile device solutions, and extended service contracts and related services for consumer electronics and appliances, and credit and other insurance products; and vehicle protection, commercial equipment protection, and other related services. The Global Housing segment provides lender-placed homeowners, manufactured housing, and flood insurance; renters insurance and other products; and voluntary manufactured housing, and condominium and homeowners insurance products. The company was formerly known as Fortis, Inc. and changed its name to Assurant, Inc. in February 2004. Assurant, Inc. was founded in 1892 and is headquartered in Atlanta, Georgia.…
Industry Peers
Insurance - Property & CasualtyKey Statistics
About Assurant (NYSE: AIZ)
›
Assurant (NYSE: AIZ) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance - Property & Casualty industry, part of the Financial Services sector, and reports about 14,800 employees.
The shares were at 316.65 USD on 20 November 2026, up 47.2% over 52 weeks. Its 52-week range is 209.86 USD to 326.99 USD: the price is 3.2% below the high and 50.9% above the low.
At a market capitalisation of 15.54B USD, it trades at 14.9 times trailing earnings and 12.9 times forward earnings. The median trailing P/E of its 19 largest Insurance - Property & Casualty peers is 12.7, a premium of 18% for AIZ. It pays a dividend yielding 1.11% (it pays out 17% of its earnings), against a median of 2.47% among the dividend payers in that peer group.
Assurant reports return on equity of 14.9%, an operating margin of 10.8% and revenue up 9.2% year over year.
Its debt exceeds its cash by 130.10M USD, a debt-to-equity ratio of 0.38. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 355.17 USD is 12.2% above the current price. The next earnings report is expected on 9 February 2027.